Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and Carcinoma, Ductal, Breast

camptothecin has been researched along with Carcinoma, Ductal, Breast in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwase, H; Kitabatake, M; Kuwahara, K; Moolthiya, P; Phimsen, S; Rezano, A; Sakaguchi, N; Suda, T; Tone, S; Yamamoto, Y; Yamamoto-Ibusuki, M1
Cai, M; Chen, L; Chowdhury, D; Gao, M; Lee, DH; Li, J; Liao, J; Pfeifer, GP; Wang, H; Xu, X; Yang, YG; Yen, Y; Zhao, A; Zhong, X1
Fujii, Y; Nakazawa, K; Shuzui, Y; Yoneto, T1

Other Studies

3 other study(ies) available for camptothecin and Carcinoma, Ductal, Breast

ArticleYear
Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.
    BMC cancer, 2013, Dec-01, Volume: 13

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Breast Neoplasms; Camptothecin; Carcinoma, Ductal, Breast; Cell Cycle Checkpoints; Cell Proliferation; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; Humans; Kaplan-Meier Estimate; MCF-7 Cells; Middle Aged; Prognosis; Proteasome Endopeptidase Complex; Protein Stability; RNA, Small Interfering; Tumor Suppressor Protein p53; Young Adult

2013
Human RIF1 encodes an anti-apoptotic factor required for DNA repair.
    Carcinogenesis, 2009, Volume: 30, Issue:8

    Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Camptothecin; Carcinoma, Ductal, Breast; Cell Differentiation; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Repair; Enzyme Inhibitors; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Staurosporine; Tumor Cells, Cultured

2009
[A case of pericardial tamponade caused by recurrent breast cancer treated with intrapericardial and intrapleural infusion of cisplatin (CDDP)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:8

    Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Carcinoma, Ductal, Breast; Cardiac Tamponade; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Infusions, Intralesional; Irinotecan; Pericardial Effusion; Pericardiocentesis; Pleural Effusion, Malignant; Pleural Neoplasms

2006